Page last updated: 2024-10-24

establishment of endothelial intestinal barrier

Definition

Target type: biologicalprocess

The establishment of a barrier between endothelial cell layers of the intestine to exert specific and selective control over the passage of water and solutes, thus allowing formation and maintenance of compartments that differ in fluid and solute composition. [GOC:krc, PMID:22155109]

The establishment of the endothelial intestinal barrier is a complex and multi-step process that involves the coordinated action of various cellular and molecular components. This barrier, also known as the intestinal microvascular barrier, serves as a selective gatekeeper, controlling the passage of nutrients, fluids, and immune cells between the intestinal lumen and the bloodstream.

Here is a detailed description of the key steps involved in the formation and maintenance of this crucial barrier:

**1. Angiogenesis and Endothelial Cell Differentiation:**

* The initial step involves the formation of new blood vessels, a process called angiogenesis. This is triggered by various growth factors and signaling molecules released by the surrounding tissues.
* As new blood vessels sprout, endothelial progenitor cells differentiate into mature endothelial cells, the specialized cells lining the inner surface of blood vessels.

**2. Tight Junction Formation:**

* Endothelial cells form tight junctions, specialized cell-cell junctions that seal the gaps between adjacent cells. This is a critical step in establishing a barrier that prevents leakage of blood components into the intestinal lumen.
* Tight junctions are composed of transmembrane proteins, such as claudins, occludin, and junctional adhesion molecules (JAMs), which interact with each other and with the cytoskeleton to create a tight seal.
* The expression and assembly of these junctional proteins are regulated by various signaling pathways, including the Rho/ROCK pathway, the VEGF pathway, and the Wnt pathway.

**3. Adherens Junction Formation:**

* Adherens junctions are another type of cell-cell junction that contributes to the structural integrity of the endothelial barrier. These junctions connect the cytoskeletons of adjacent cells, providing tensile strength and stability.
* Adherens junctions are primarily formed by the interaction of cadherin proteins, such as vascular endothelial cadherin (VE-cadherin), with the intracellular catenins.

**4. Basement Membrane Formation:**

* Endothelial cells are anchored to the underlying extracellular matrix (ECM) by a specialized structure called the basement membrane. This thin, sheet-like structure provides structural support and regulates cell adhesion and signaling.
* The basement membrane is primarily composed of type IV collagen, laminin, and other ECM components. Its formation involves the secretion of these molecules by endothelial cells and other cell types.

**5. Paracellular Transport Regulation:**

* The endothelial intestinal barrier is not impermeable; it allows controlled passage of molecules through the spaces between endothelial cells (paracellular pathway).
* The permeability of the paracellular pathway is regulated by the tight junctions. Different claudin isoforms, for example, can create pores with varying sizes, influencing the passage of specific molecules.
* Moreover, various signaling pathways, such as the inflammatory signaling pathways, can alter the permeability of the paracellular pathway, leading to increased leakage.

**6. Transcellular Transport Regulation:**

* In addition to paracellular transport, molecules can also cross the endothelial barrier through the cells themselves (transcellular pathway).
* Transcellular transport is mediated by specific transporters and receptors expressed on the endothelial cell surface. These proteins can facilitate the uptake and transport of nutrients, metabolites, and other molecules across the barrier.

**7. Immune Cell Recruitment and Response:**

* The endothelial intestinal barrier plays a crucial role in immune surveillance. It regulates the recruitment of immune cells from the bloodstream to the intestinal lumen.
* Endothelial cells express adhesion molecules, such as selectins and integrins, which bind to specific ligands on leukocytes, facilitating their attachment to the vessel wall.
* Upon activation, endothelial cells can also produce chemokines, which attract immune cells to the site of inflammation or infection.

**8. Maintenance and Remodeling:**

* The endothelial intestinal barrier is not static but is constantly being remodeled in response to various stimuli, including changes in nutrient availability, pathogen exposure, and inflammatory signals.
* Endothelial cells are capable of proliferation, migration, and apoptosis, allowing for dynamic adaptation of the barrier to maintain its integrity and function.

**9. Barrier Dysfunction and Disease:**

* Disruption of the endothelial intestinal barrier, often referred to as "barrier dysfunction," is a hallmark of several gastrointestinal diseases, including inflammatory bowel disease (IBD), celiac disease, and irritable bowel syndrome (IBS).
* Factors that can contribute to barrier dysfunction include infections, inflammation, autoimmune responses, and environmental toxins.
* Loss of barrier integrity can lead to increased intestinal permeability, allowing harmful substances to leak into the bloodstream, triggering immune responses and contributing to disease pathogenesis.

In summary, the establishment of the endothelial intestinal barrier is a tightly regulated process that involves numerous cellular and molecular components. This barrier plays a critical role in maintaining intestinal homeostasis and protecting the host from infection and inflammation. However, disruption of this barrier can contribute to the development and progression of various gastrointestinal diseases.

'"

Proteins (2)

ProteinDefinitionTaxonomy
Receptor-type tyrosine-protein phosphatase SA receptor-type tyrosine-protein phosphatase S that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q13332]Homo sapiens (human)
Fatty acid synthaseA fatty acid synthase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P49327]Homo sapiens (human)

Compounds (32)

CompoundDefinitionClassesRoles
lansoprazoleLansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.benzimidazoles;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
omeprazole5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
aromatic ether;
benzimidazoles;
pyridines;
sulfoxide
pantoprazolepantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
aromatic ether;
benzimidazoles;
organofluorine compound;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
environmental contaminant;
xenobiotic
rabeprazoleRabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.benzimidazoles;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
methioninemethionine : A sulfur-containing amino acid that is butyric acid bearing an amino substituent at position 2 and a methylthio substituent at position 4.

Methionine: A sulfur-containing essential L-amino acid that is important in many body functions.
aspartate family amino acid;
L-alpha-amino acid;
methionine;
methionine zwitterion;
proteinogenic amino acid
antidote to paracetamol poisoning;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical
3-hydroxyflavone3-hydroxyflavone: structure given in first source

flavonol : A monohydroxyflavone that is the 3-hydroxy derivative of flavone.
flavonols;
monohydroxyflavone
epigallocatechin gallate(-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin.

epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis)
flavans;
gallate ester;
polyphenol
antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
epicatechin(-)-epicatechin : A catechin with (2R,3R)-configuration.catechin;
polyphenol
antioxidant
(+)-epicatechin(+)-epicatechin : A catechin that is flavan carrying five hydroxy substituents at positions 3, 3', 4', 5 and 7 (the 2S,3S-stereoisomer).catechin;
polyphenol
cyclooxygenase 1 inhibitor;
plant metabolite
s-adenosylhomocysteineS-adenosyl-L-homocysteine : An organic sulfide that is the S-adenosyl derivative of L-homocysteine.

S-Adenosylhomocysteine: 5'-S-(3-Amino-3-carboxypropyl)-5'-thioadenosine. Formed from S-adenosylmethionine after transmethylation reactions.
adenosines;
amino acid zwitterion;
homocysteine derivative;
homocysteines;
organic sulfide
cofactor;
EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitor;
EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor;
epitope;
fundamental metabolite
5'-methylthioadenosine5'-methylthioadenosine: structure

5'-S-methyl-5'-thioadenosine : Adenosine with the hydroxy group at C-5' substituted with a methylthio (methylsulfanyl) group.
thioadenosinealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
egonolegonol : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a methoxy group at position 7, a 1,3-benzodioxol-5-yl group at position 2 and a 3-hydroxypropyl group at position 5. It has been isolated from Styrax agrestis.1-benzofurans;
aromatic ether;
benzodioxoles;
primary alcohol
plant metabolite
orlistatorlistat : A carboxylic ester resulting from the formal condensation of the carboxy group of N-formyl-L-leucine with the hydroxy group of (3S,4S)-3-hexyl-4-[(2S)-2-hydroxytridecyl]oxetan-2-one. A pancreatic lipase inhibitor, it is used as an anti-obesity drug.

Orlistat: A lactone derivative of LEUCINE that acts as a pancreatic lipase inhibitor to limit the absorption of dietary fat; it is used in the management of obesity.
beta-lactone;
carboxylic ester;
formamides;
L-leucine derivative
anti-obesity agent;
bacterial metabolite;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor
luteolin3'-hydroxyflavonoid;
tetrahydroxyflavone
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
c-Jun N-terminal kinase inhibitor;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
immunomodulator;
nephroprotective agent;
plant metabolite;
radical scavenger;
vascular endothelial growth factor receptor antagonist
baicaleintrihydroxyflavoneangiogenesis inhibitor;
anti-inflammatory agent;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 4.1.1.17 (ornithine decarboxylase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hormone antagonist;
plant metabolite;
prostaglandin antagonist;
radical scavenger
gentiseingentisein : A member of the class of xanthones that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 3 and 7.

gentisein: isolated from the methanol extract of the herb of Hypericum annulatum; structure in first source
polyphenol;
xanthones
plant metabolite
mangostinalpha-mangostin : A member of the class of xanthones that is 9H-xanthene substituted by hydroxy group at positions 1, 3 and 6, a methoxy group at position 7, an oxo group at position 9 and prenyl groups at positions 2 and 8. Isolated from the stems of Cratoxylum cochinchinense, it exhibits antioxidant, antimicrobial and antitumour activities.

mangostin: xanthone from rind of Garcinia mangostana Linn. fruit
aromatic ether;
phenols;
xanthones
antimicrobial agent;
antineoplastic agent;
antioxidant;
plant metabolite
norathyriolnorathyriol : A member of the class of xanthones that is 9H-xanthen-9-one substituted by hydroxy groups at positions 1, 3, 6 and 7. Isolated from Garcinia mangostana and Maclura pomifera, it exhibits inhibitory activity against protein kinase C.

norathyriol: from Gentinanaceae; has vasorelaxing action on rat thoracic aorta; structure given in first source
polyphenol;
xanthones
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
plant metabolite
morinmorin : A pentahydroxyflavone that is 7-hydroxyflavonol bearing three additional hydroxy substituents at positions 2' 4' and 5.

morin: a light yellowish pigment found in the wood of old fustic (Chlorophora tinctoria)
7-hydroxyflavonol;
pentahydroxyflavone
angiogenesis modulating agent;
anti-inflammatory agent;
antibacterial agent;
antihypertensive agent;
antineoplastic agent;
antioxidant;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
hepatoprotective agent;
metabolite;
neuroprotective agent
scutellareinscutellarein : Flavone substituted with hydroxy groups at C-4', -5, -6 and -7.

scutellarein: aglycone of scutellarin from Scutellaria baicalensis; carthamidin is 2S isomer of scutellarein; do not confuse with isoscutellarein and/or isocarthamidin which are respective regioisomers, or with the scutelarin protein
tetrahydroxyflavonemetabolite
tricetintricetin : Flavone hydroxylated at positions 3', 4', 5, 5' and 7.pentahydroxyflavoneantineoplastic agent;
metabolite
cerulenincerulenin : An epoxydodecadienamide isolated from several species, including Acremonium, Acrocylindrum and Helicoceras. It inhibits the biosynthesis of several lipids by interfering with enzyme function.

Cerulenin: An epoxydodecadienamide isolated from several species, including ACREMONIUM, Acrocylindrum, and Helicoceras. It inhibits the biosynthesis of several lipids by interfering with enzyme function.
epoxide;
monocarboxylic acid amide
antifungal agent;
antiinfective agent;
antilipemic drug;
antimetabolite;
antimicrobial agent;
fatty acid synthesis inhibitor
trans-10,cis-12-conjugated linoleic acid(10E,12Z)-octadecadienoic acid : An octadeca-10,12-dienoic acid having (10E,12Z)-configuration.octadeca-10,12-dienoic acid
gamma-mangostingamma-mangostin : A member of the class of xanthones that is 9H-xanthene substituted by hydroxy group at positions 1, 3, 6 and 7, an oxo group at position 9 and prenyl groups at positions 2 and 8. Isolated from the stems of Cratoxylum cochinchinense, it exhibits antitumour activity.phenols;
xanthones
antineoplastic agent;
plant metabolite;
protein kinase inhibitor
beta-Mangostinxanthones
9-Hydroxycalabaxanthonexanthones
4-methylene-2-octyl-5-oxofuran-3-carboxylic acid(2R,3S)-C75 : A 4-methylidene-2-octyl-5-oxotetrahydrofuran-3-carboxylic acid that has 2R,3S-configuration.

4-methylene-2-octyl-5-oxofuran-3-carboxylic acid: an anorectic fatty acid synthase inhibitor; structure in first source
4-methylidene-2-octyl-5-oxotetrahydrofuran-3-carboxylic acid;
gamma-lactone
garcinone egarcinone E: has potent cytotoxic effect against hepatocellular carcinoma cell lines; structure in first sourcexanthones
omdm 169OMDM 169: has antinociceptive activity; structure in first source
gsk837149aGSK837149A: structure in first source
gsk2194069GSK2194069: a beta-ketoacyl reductase inhibitor; structure in first source
thiolactomycinthiolactomycin: from actinomycetes; structure given in first source